After being accepted into a study, qualified research volunteers will be expected to return to the COVID-19 study centers for follow-up monitoring and treatment visits for a specific period of time after vaccination visits or treatment visits. It is possible that some of these visits could be remote live visits using special medical live-chat software developed to reduce unnecessary travel.

​

Approved study clinicians will monitor all participants for common vaccination symptoms including soreness at the injection site or fever. Also, a team of medical doctors related to the specific study will meet regularly to review any unusual clinical trial data and any adverse medical responses reported to a research site.

 

Each investigational vaccine study's success will be measured for its strength and the effectiveness of immune response, as well as its long-term effectiveness and safety when used with various age, geographic, ethnic populations, at a variety of health levels.